Over the past five years, GiveWell has expanded the scale of our grantmaking and team substantially. We expect to grant more than $1 billion this year, more than double the $418 million we committed in 2025. Alongside this grantmaking growth, we’ve more than doubled the number of researchers on our team since the start of last year. A larger team means we can investigate a greater number of both more complex and larger funding opportunities than we could before. One area where we expect our grantmaking to increase substantially in the coming years is the prevention and treatment of malaria.
From 2027 through 2032, we’re aiming to grant at least $2.5 billion in new malaria funding, potentially several times that amount. The total amount will depend on the funding we have available, the feasibility of scaling up cost-effective malaria programs, countries’ appetite for those programs, and how opportunities within malaria compare to other grantmaking areas. This expanded support could go to organizations we currently fund (such as the Against Malaria Foundation and Malaria Consortium), as well as to new organizations and novel funding vehicles. We are still in the process of assessing which strategies for deploying new malaria funding are likely to be highly cost-effective and scalable, and are currently exploring partnerships with the Global Fund and Gavi to help rapidly scale our impact across many programs in many countries at once.
While this post focuses on our malaria work, we are also growing our grantmaking in other areas. This includes areas we have supported for many years, such as treatment for severe malnutrition, efforts to increase childhood vaccination, and programs to provide safe drinking water, as well as areas we have supported at relatively smaller scale to date, such as medical oxygen, tuberculosis control, and family planning. We currently expect to grant more than $1 billion to program areas outside malaria in 2027, and we think we could grant more with additional funding. While the scale of our grantmaking is growing, we’ll remain focused on researching the most cost‑effective ways to save and improve lives, sharing our work openly, and directing donations to help people in need as much as we can.
